AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,544,000 | -34.6% | 186,964 | 0.0% | 0.24% | -35.7% |
| Q2 2020 | $9,999,000 | +50.7% | 186,964 | 0.0% | 0.38% | +27.0% |
| Q1 2020 | $6,633,000 | -35.8% | 186,964 | -13.6% | 0.30% | -23.3% |
| Q4 2019 | $10,333,000 | +124.2% | 216,408 | +52.2% | 0.39% | +94.5% |
| Q3 2019 | $4,608,000 | -36.4% | 142,217 | -2.2% | 0.20% | -32.1% |
| Q2 2019 | $7,250,000 | +17.1% | 145,342 | +58.4% | 0.30% | +17.9% |
| Q1 2019 | $6,189,000 | +173.7% | 91,776 | +87.2% | 0.25% | +158.8% |
| Q4 2018 | $2,261,000 | -13.4% | 49,025 | +44.7% | 0.10% | +2.1% |
| Q3 2018 | $2,612,000 | +1002.1% | 33,870 | +1105.3% | 0.10% | +955.6% |
| Q2 2018 | $237,000 | +3.0% | 2,810 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $230,000 | -97.6% | 2,810 | -97.2% | 0.01% | -97.6% |
| Q1 2015 | $9,458,000 | +82.7% | 100,300 | +117.1% | 0.38% | +55.0% |
| Q4 2014 | $5,176,000 | +141.1% | 46,200 | +32.0% | 0.24% | +139.6% |
| Q3 2014 | $2,147,000 | – | 35,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |